Ferrer-Montiel A V, Merino J M, Planells-Cases R, Sun W, Montal M
Department of Biology, University of California San Diego, La Jolla 92093-0366, USA.
Neuropharmacology. 1998;37(2):139-47. doi: 10.1016/s0028-3908(98)00007-0.
Glutamate receptor channels of the NMDA-type (N-methyl-D-aspartate) and non-NMDA-type (GluR) differ in their pore properties. The N-site in the M2 transmembrane segment of NMDA receptors (NMDAR), or the corresponding Q/R-site in GluRs, is a pivotal structural determinant of their permeation and blockade characteristics. Substitutions at a second site in M2, the L-site (L577) in GluR1, drastically alter the receptor selectivity to divalent cations. Here we report that M2 mutants carrying an asparagine or a threonine residue at the Q-site of GluR1, along with a tryptophan residue at the L-site, form homomeric GluR1 channels that are highly sensitive to structurally diverse, uncompetitive NMDA antagonists such as arylcyclohexylamines, dibenzocycloheptenimines, and to morphinian and adamantane derivatives. Analysis of the voltage dependence of channel blockade locates the blocker binding site approximately 0.65 partway into the transmembrane electric field in both GluR1 mutants and NMDAR channels. Our results suggest that the homomeric GluR1 double mutants, L577W/Q582N and L577W/Q582T, fairly approximate the pore properties of the heteromeric NMDA receptor and support the structural kinship of their permeation pathways.
N-甲基-D-天冬氨酸(NMDA)型和非NMDA型(GluR)的谷氨酸受体通道在其孔道特性上存在差异。NMDA受体(NMDAR)M2跨膜片段中的N位点,或GluRs中对应的Q/R位点,是其通透和阻断特性的关键结构决定因素。GluR1中M2的第二个位点即L位点(L577)发生替换,会极大地改变受体对二价阳离子的选择性。在此我们报告,在GluR1的Q位点携带天冬酰胺或苏氨酸残基且在L位点携带色氨酸残基的M2突变体,形成了对结构多样的非竞争性NMDA拮抗剂(如芳基环己胺、二苯并环庚烯亚胺以及吗啡和金刚烷衍生物)高度敏感的同聚体GluR1通道。对通道阻断电压依赖性的分析表明,在GluR1突变体和NMDAR通道中,阻断剂结合位点大约位于跨膜电场的0.65处。我们的结果表明,同聚体GluR1双突变体L577W/Q582N和L577W/Q582T相当近似异聚体NMDA受体的孔道特性,并支持其通透途径的结构亲缘关系。